HighlightsReceived full production run of approximately 20,000 BPC-157 transdermal patches, the Company's lead product ...

The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that ...

Order placed for 20,000 units of the Company's lead product candidate, a needle-free BPC-157 transdermal patch, in preparation for commercial release Initial commercial release of the BPC-157 ...

First wearable peptide patch designed to expand BPC-157 beyond injectables and establish a multi-product transdermal peptide platform under Amino Innovations Vancouver, British Columbia--(Newsfile ...

Order placed for 20,000 units of the Company's lead product candidate, a needle-free BPC-157 transdermal patch, in preparation for commercial release Initial commercial release of the BPC-157 ...

STAT is co-publishing this with Undark. This story was supported by the Pulitzer Center. In 1975, in a medical school classroom in what was then the Socialist Federal Republic of Yugoslavia, Predrag ...

BPC-157 and TB-500, originating from gastric and thymic sources respectively, both influence angiogenesis, cytoskeletal regulation, and extracellular matrix remodelling. Their combined effects may ...

HighlightsReceived full production run of approximately 20,000 BPC-157 transdermal patches, the Company's lead product candidatePatches are manufactured and independently tested in the United StatesMa ...